Abstract
Previous studies demonstrated the critical role of miRNAs in carcinogenesis. Aberrant expression of miR-127-3p and miR-144-3p have been revealed in several types of cancers. Expression levels of miR-127-3p and miR-144-3p were detected in the plasma of patients with gastric cancer (GC) using fluorescent quantitative polymerase chain reaction to recognize potential non-invasive biomarkers for GC and evaluated the relationship between their expression and clinicopathological parameters of GC. The results showed miR-127-3p and miR-144-3p expression levels were significantly decreased in plasma of GC patients (p = 0.003 and p < 0.001, respectively) and the expression level of miR-144-3p was associated with tumor-node-metastasis (TNM) staging. In addition, receiver operating characteristic (ROC) curve analysis indicated the area of miR-127-3p and miR-144-3p under the ROC curve for GC diagnosis were 0.664 and 0.741, re-spectively (p < 0.05). The expression levels of miR-127-3p and -144-3p were downregulated in the plasma of GC patients that may participate in the pathological process of GC and act as potential tumor biomarkers.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.